The Risk of Myocarditis/Pericarditis After the Sacred Vax By Brian Simpson

A recent study from Hong Kong has shown that the risk of acute myocarditis/pericarditis (conditions that can have very life-limiting/shortening consequences) due to the Pfizer vaccine in 12-17-year-old males is approximately 1 in 2,500. This is much higher than their risk of deleterious consequences from the Covid-19 disease with no co-morbidities.  Hence, the Covid vaxxes for this age group alone, is nonsensical. But the whole plandemic is not about following medical science, done in an evidence-based way, but pursuing New World Order political control and subservience, before the great transhuman replacement.

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab989/6445179?login=true

“Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination

Gilbert T Chua, FHKCPaed, FHKAM(Paed), Mike Yat Wah Kwan, MSc(Applied Epidemiology) CUHK, Celine S L Chui, PhD, Robert David Smith, PhD, Edmund Chi-Lok Cheung, BSc, Tian Tian, Ma, PhD, Miriam T Y Leung, BPharm, Sabrina Siu Ling Tsao, MBBS(UK), FACC(USA), Elaine Kan, FRCR, FHKCR, Wing Kei Carol Ng, FRCR, FHKAM ... Show more

Author Notes

Clinical Infectious Diseases, ciab989, https://doi.org/10.1093/cid/ciab989

Published:

28 November 2021

Abstract

Background

Age-specific incidence of acute myocarditis/pericarditis in adolescents following Comirnaty vaccination in Asia is lacking. This study aimed to study the clinical characteristics and incidence of acute myocarditis/pericarditis among Hong Kong adolescents following Comirnaty vaccination.

Methods

This is a population cohort study in Hong Kong that monitored adverse events following immunization through a pharmacovigilance system for COVID-19 vaccines. All adolescents aged between 12 and 17 years following Comirnaty vaccination were monitored under the COVID-19 vaccine Adverse Event Response and Evaluation Programme. The clinical characteristics and overall incidence of acute myocarditis/pericarditis in adolescents following Comirnaty vaccination were analysed.

Results

Between 14 June 2021 and 4 September 2021, 33 Chinese adolescents who developed acute myocarditis/pericarditis following Comirnaty vaccination were identified. 29 (87.88%) were males and 4 (12.12%) were females, with a median age of 15.25 years. 27 (81.82%) and 6 (18.18%) cases developed acute myocarditis/pericarditis after receiving the second and first dose, respectively. All cases are mild and required only conservative management.The overall incidence of acute myocarditis/pericarditis was 18.52 (95% Confidence Interval [CI], 11.67-29.01) per 100,000 persons vaccinated. The incidence after the first and second doses were 3.37 (95%CI 1.12-9.51) and 21.22 (95%CI 13.78-32.28 per 100,000 persons vaccinated, respectively. Among male adolescents, the incidence after the first and second doses were 5.57 (95% CI 2.38-12.53) and 37.32 (95% CI 26.98-51.25) per 100,000 persons vaccinated.

Conclusions

There is a significant increase in the risk of acute myocarditis/pericarditis following Comirnaty vaccination among Chinese male adolescents, especially after the second dose.”